Resistance mechanisms to mTOR inhibition in renal cancer

Resistance mechanisms to mTOR inhibition in renal cancer

<p><b>Introduction</b>: Advanced clear cell renal cell cancer (CCRCC) is incurable, but molecularly targeted treatments have improved the prognosis. One such molecular target is the mammalian target of rapamycin (mTOR) and two rapalogues (everolimus and temsirolimus) have been lice...

Bibliografske podrobnosti
Glavni avtor:	Earwaker, P
Drugi avtorji:	Macaulay, V
Format:	Thesis
Jezik:	English
Izdano:	2015

Podobne knjige/članki

The effects of mTOR inhibition in ischemic stroke
od: Schneider, AM
Izdano: (2022)

RAPTOR up-regulation contributes to resistance of renal cancer cells to PI3K-mTOR inhibition PONE-D-17-28641
od: Earwa, P, et al.
Izdano: (2018)

Influenza vaccines: mTOR inhibition surprisingly leads to protection.
od: Mcmichael, A, et al.
Izdano: (2013)

Insights into the regulation of mTOR signaling and the consequences of pharmacological inhibition
od: Thoreen, Carson Cornell
Izdano: (2009)

Reversal of phenotypes of cellular senescence by pan-mTOR inhibition
od: Cox, L, et al.
Izdano: (2016)

mTOR and cancer: many loops in one pathway
od: Efeyan, Alejo, et al.
Izdano: (2012)

mTOR Signalling, Nutrients and Disease
od: Goberdhan, D, et al.
Izdano: (2008)

The mTOR pathway and integrating immune regulation.
od: Cobbold, S
Izdano: (2013)

mTOR Signaling in Growth Control and Disease
od: Laplante, Mathieu, et al.
Izdano: (2014)

An emerging role of mTOR in lipid biosynthesis
od: Laplante, Mathieu, et al.
Izdano: (2012)

mTOR Signaling in Growth, Metabolism, and Disease
od: Saxton, Robert Andrew, et al.
Izdano: (2018)

Structure of the human mTOR Complex I and its implications for rapamycin inhibition
od: Yip, Calvin K., et al.
Izdano: (2012)

mTOR: from growth signal integration to cancer, diabetes and ageing
od: Zoncu, Roberto, et al.
Izdano: (2012)

mTOR: dissecting regulation and mechanism of action to understand human disease.
od: Goberdhan, D, et al.
Izdano: (2009)

The Adaptor Protein p66Shc Inhibits mTOR-Dependent Anabolic Metabolism
od: Lamming, Dudley W., et al.
Izdano: (2015)

The mTOR-Regulated Phosphoproteome Reveals a Mechanism of mTORC1-Mediated Inhibition of Growth Factor Signaling
od: Rameseder, J., et al.
Izdano: (2013)

The TSC-mTOR pathway regulates macrophage polarization
od: Byles, Vanessa, et al.
Izdano: (2015)

mTOR at the nexus of nutrition, growth, ageing and disease
od: Liu, Grace Y, et al.
Izdano: (2021)

mTOR signalling and metabolic regulation of T cell differentiation.
od: Peter, C, et al.
Izdano: (2010)

mTOR signalling and the regulation of Hoxp3 expression
od: Peter, C
Izdano: (2013)

A Central Role for mTOR in Lipid Homeostasis
od: Lamming, Dudley W., et al.
Izdano: (2016)

LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression
od: Blagden, S, et al.
Izdano: (2015)

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
od: Carbonneau, M, et al.
Izdano: (2016)

mTOR regulates memory CD8 T-cell differentiation.
od: Araki, K, et al.
Izdano: (2009)

Amino acid sensing and mTOR regulation: inside or out?
od: Goberdhan, D, et al.
Izdano: (2009)

The role of tryptophan and the mTOR pathway in T cell fate determination
od: Karydis, I, et al.
Izdano: (2014)

The identification of the mTOR-regulated phosphoproteome and a mediator of feedback inhibition to P13K-Akt
od: Hsu, Peggy Ping
Izdano: (2011)

Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
od: Lindblad, O, et al.
Izdano: (2017)

Dysfunction of the mTOR pathway is a risk factor for Alzheimer's disease.
od: Yates, S, et al.
Izdano: (2013)

Inositol-6 phosphate inhibits the mTOR pathway and induces autophagy-mediated death in HT-29 colon cancer cells
od: Pandurangan, Ashok Kumar, et al.
Izdano: (2018)

Inositol-6 phosphate inhibits the mTOR pathway and induces autophagy-mediated death in HT-29 colon cancer cells
od: Pandurangan, Ashok Kumar, et al.
Izdano: (2018)

Genetic variability of the mTOR pathway and prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)
od: Campa, D, et al.
Izdano: (2011)

mTOR-S6K1 pathway mediates cytoophidium assembly
od: Sun, Z, et al.
Izdano: (2019)

Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia
od: Hadley, G, et al.
Izdano: (2019)

Regulation of mTOR complex 1 in response to growth factors and nutrients
od: Sancak, Yasemin S. (Yasemin Shechner)
Izdano: (2010)

The role of the mTor pathway for the development of the mouse thymic epithelium and function
od: Berkemeier, C, et al.
Izdano: (2010)

mTOR Complex 2 Is Required for the Development of Prostate Cancer Induced by Pten Loss in Mice
od: Guertin, David A., et al.
Izdano: (2015)

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones
od: Cavazzoni, A, et al.
Izdano: (2012)

Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones.
od: Cavazzoni, A, et al.
Izdano: (2012)

Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.
od: Fokas, E, et al.
Izdano: (2012)